Speaker: Nader Fotouhi, Chief Scientific Officer, TB Alliance (USA)

Moderator: Lydia Nakiyingi, infectious diseases physician, research scientist and senior lecturer, Makerere University College of Health Sciences (Uganda)

Nader’s presentation discussed:

• 20 Years of Impact: Introduction to TB Alliance and an overview of TB drug development in the 21^st century
• The TB drug discovery and development landscape today: state of the global pipeline and survey of TB Alliance’s programs
• Case study: a new therapy for highly drug-resistant forms of TB
• Where do we go from here? New partnerships and new treatment paradigms to reimagine TB treatment

This live webinar including interactive Q&A session was broadcast on 24 March 2021.

If you have questions or comments, please let us know: revive@gardp.org.